PKTXOTCPharmaceutical PreparationsFiscal year ends December 31
ProtoKinetix, Inc.
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 10-K on Sep 3, 2026
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $78.61K
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
ProtoKinetix has not reported a dividend
No dividend per share appears in ProtoKinetix's annual filings since fiscal 2010.